Company: GAUZ
Filing Date: 2025-07-03
Form Type: F-3
Source: 0001213900-25-061387
Chunk: 2

Company: Gauzy Ltd.
Filing Date: 2025-07-03
Form: F-3
Chunk 2
---
000 in the aggregate of ordinary shares, warrants, debt securities, subscription
rights and/or units consisting of two or more of these classes or series of securities.

We refer to the ordinary shares, warrants, debt
securities, subscription rights and units collectively as “securities” in this prospectus.

Each time we sell securities pursuant to this prospectus,
we will provide a supplement to this prospectus that contains specific information about the offeror, the offering and the specific terms
of the securities offered. This prospectus may not be used to consummate a sale of securities by us unless accompanied by the applicable
prospectus supplement. You should read this prospectus and the applicable prospectus supplement carefully before you invest in our securities.

We may, from time to time, offer to sell the securities,
through public or private transactions, directly or through underwriters, agents or dealers, on or off the Nasdaq Global Market, as applicable,
at prevailing market prices or at privately negotiated prices. If any underwriters, agents or dealers are involved in the sale of any
of these securities, the applicable prospectus supplement will set forth the names of the underwriter, agent or dealer and any applicable
fees, commissions or discounts. For general information about the distribution of securities offered, please see “Plan of Distribution”
beginning on page 22 of this prospectus.

Our ordinary shares are listed on the Nasdaq Global
Market under the trading symbol “GAUZ”. On July 1, 2025, the closing price for our ordinary shares on the Nasdaq Global Market
was $8.13 per ordinary share.

We are an “emerging growth company”
and a “foreign private issuer” under applicable Securities and Exchange Commission, or the SEC, rules, and, as such, we have
elected to comply with certain reduced public company reporting requirements for this prospectus and future filings.

Investing in these securities involves a high degree of risk. Please carefully consider the risks discussed in this prospectus under “Risk Factors” beginning on page 4 and the “Risk Factors” in “Item 3: Key Information- Risk Factors” of our most recent Annual Report on Form 20-F incorporated by reference in this prospectus and in any applicable prospectus supplement for a discussion of the factors you should consider carefully before deciding to purchase these securities.

Neither the SEC nor any state securities commission has approved or disapproved of the securities being offered by this prospectus, or determined if this prospectus is truthful or complete